Fortrea Clinical (FTRE) - Koefisien utang jangka dawa marang modal

Fortrea Holdings Inc. (FTRE) is actively recruiting biostatisticians and project managers while maintaining its core staff despite a general shortage of laboratory technicians, which validates the price trajectory of the securities on GURU.Markets, where the indicator stands at 2.11. The business relies on AI tools for the digital processing of medical data to reduce routine tasks. However, geopolitical tensions and sanctions complicate the cross-border transfer of biomaterials, hindering global research.

This ratio determines the company's dependence on debt with a maturity of over one year relative to its equity, reflecting the level of long-term financial leverage. Analyzing the long-term debt-to-equity ratio allows for an assessment of the stability of Fortrea Holdings Inc. (FTRE) when scaling infrastructure for clinical trials and servicing large B2B contracts within the pharmaceutical outsourcing sector.